UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Rapid disease course in African Americans with multiple sclerosis

Neurology, 2010-07, Vol.75 (3), p.217

2010

Link zum Volltext

Verfügbarkeit prüfen

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-03, Vol.13 (3), p.247-256

2014

Link zum Volltext

Verfügbarkeit prüfen

Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice

Chemical senses, 2001-10, Vol.26 (8), p.937-952

2001

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

Neurology, 1999-10, Vol.53 (6), p.1225

1999

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and management of postpolio syndrome

JAMA : the journal of the American Medical Association, 2000-07, Vol.284 (4), p.412

2000

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal correlates of fatigue in multiple sclerosis

Multiple sclerosis, 2009-02, Vol.15 (2), p.258-261

2009

Link zum Volltext

Verfügbarkeit prüfen

Functional Consequences Following Infection of the Olfactory System by Intranasal Infusion of the Olfactory Bulb Line Varient (OBLV) of Mouse Hepatitis Strain JHM

Chemical senses, 2001-10, Vol.26 (8), p.953-963

2001

Link zum Volltext

Verfügbarkeit prüfen

Post-polio Syndrome: An Update

Seminars in neurology, 1993-09, Vol.13 (3), p.283-290

1993

Link zum Volltext

Verfügbarkeit prüfen

A profile of multiple sclerosis patients treated for at least five years with the same disease-modifying agent at the Syracuse MS Clinic

Multiple sclerosis, 2008-09, Vol.14, p.S163-S163

2008

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Journal of the neurological sciences, 2010-05, Vol.292 (1), p.28-35

2010

Link zum Volltext

Verfügbarkeit prüfen

Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome

Journal of the neurological sciences, 2001, Vol.182 (2), p.107-115

2001

Link zum Volltext

Verfügbarkeit prüfen

Does viral disease underlie ALS? Lessons from the AIDS pandemic

Neurology, 2001-09, Vol.57 (6), p.945

2001

Link zum Volltext

Verfügbarkeit prüfen

Viruses and motor neuron diseases

Advances in neurology, 1991, Vol.56, p.463

Jubelt, B

1991

Link zum Volltext

Verfügbarkeit prüfen

Reverse transcriptase takes ALS back to viruses

Neurology, 2005-02, Vol.64 (3), p.410

2005

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium

Multiple sclerosis, 2003-06, Vol.9 (3), p.293-298

2003

Link zum Volltext

Verfügbarkeit prüfen

Antibody Titer to the Poliovirus in Blood and Cerebrospinal Fluid of Patients with Post-Polio Syndrome

Annals of the New York Academy of Sciences, 1995-05, Vol.753 (1), p.201-207

1995

Link zum Volltext

Verfügbarkeit prüfen

ALS: persistent scientists do not find persisting enteroviruses

Neurology, 2004-04, Vol.62 (8), p.1250

2004

Link zum Volltext

Verfügbarkeit prüfen

Interferon- beta treatment of multiple sclerosis patients induces SHP-1 expression and modulates pro-inflammatory gene expression in peripheral blood mononuclear cells in vivo

Multiple sclerosis, 2008-09, Vol.14, p.S129-S129

2008

Link zum Volltext

Verfügbarkeit prüfen

Interferon- beta modulates STAT6-activated inflammatory gene expression through the induction of SHP-1 in multiple sclerosis PBMCs

Multiple sclerosis, 2008-09, Vol.14, p.S232-S232

2008

Link zum Volltext

Verfügbarkeit prüfen

Interferon-b treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

Clinical immunology (Orlando, Fla.), 2009-10, Vol.133 (1), p.27-44

2009

Link zum Volltext

Verfügbarkeit prüfen

Peripheral nervous system involvement in multiple sclerosis

Neurology, 1991-03, Vol.41 (3), p.457

1991

Link zum Volltext

Verfügbarkeit prüfen

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

Neurology, 2002-11, Vol.59 (10), p.1568

2002

Link zum Volltext

Verfügbarkeit prüfen

Neurotrophic and neuroprotective effects of milk thistle (Silybum marianum) on neurons in culture

Journal of molecular neuroscience, 2002-06, Vol.18 (3), p.265-269

2002

Link zum Volltext

Verfügbarkeit prüfen

Neurological manifestations of the post-polio syndrome

Critical reviews in neurobiology, 1987, Vol.3 (3), p.199

1987

Link zum Volltext

Verfügbarkeit prüfen

Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas

Current opinion in neurology and neurosurgery, 1992-10, Vol.5 (5), p.655

Jubelt, B

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rapid disease course in African Americans with multiple sclerosis

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

Characteristics and management of postpolio syndrome

Longitudinal correlates of fatigue in multiple sclerosis

Functional Consequences Following Infection of the Olfactory System by Intranasal Infusion of the Olfactory Bulb Line Varient (OBLV) of Mouse Hepatitis Strain JHM

Post-polio Syndrome: An Update

A profile of multiple sclerosis patients treated for at least five years with the same disease-modifying agent at the Syracuse MS Clinic

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome

Does viral disease underlie ALS? Lessons from the AIDS pandemic

Viruses and motor neuron diseases

Reverse transcriptase takes ALS back to viruses

Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium

Antibody Titer to the Poliovirus in Blood and Cerebrospinal Fluid of Patients with Post-Polio Syndrome

ALS: persistent scientists do not find persisting enteroviruses

Interferon- beta treatment of multiple sclerosis patients induces SHP-1 expression and modulates pro-inflammatory gene expression in peripheral blood mononuclear cells in vivo

Interferon- beta modulates STAT6-activated inflammatory gene expression through the induction of SHP-1 in multiple sclerosis PBMCs

Interferon-b treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

Peripheral nervous system involvement in multiple sclerosis

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

Neurotrophic and neuroprotective effects of milk thistle (Silybum marianum) on neurons in culture

Neurological manifestations of the post-polio syndrome

Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas

Suchergebnisse filtern